OMICS International https://www.omicsonline.org/ OMICS International is a scientific organization that drives the progress of research through open access journals and organizes international conferences, The best in science news, commentary, and research. https://www.omicsgroup.org/journals/ArchiveIME/currentissue-internal-medicine-open-access.php Internal Medicine: Open Access Volume 7, Issue 2 https://www.omicsgroup.org/journals/post-infantile-giant-cell-hepatitis-pigch-induced-by-habitual-therapeuticdosing-of-acetaminophen-2165-8048-1000i115.php?aid=87802 Post Infantile Giant Cell Hepatitis PIGCH Induced by Habitual TherapeuticDosing of Acetaminophen Alhaddad OM, Elsabaawy MM, Essa MS, Shaaban A, Elsaharaawy O, Ehsan NA, Maher D, Kohla M https://www.omicsgroup.org/journals/disabling-bilateral-hip-disease-and-femoral-bone-defects-revealing-systemicsarcoidosis-2165-8048-1000235.php?aid=87799 Disabling Bilateral Hip Disease and Femoral Bone Defects Revealing SystemicSarcoidosis Baccouche K, Amdoun DE, Bouzaoueche M, Belghali S, Zaghouani H, Zeglaoui H, Bouajina E https://www.omicsgroup.org/journals/novel-biomarkers-in-prediction-of-heart-failure-related-outcomes-from-benchto-bedside-2165-8048-1000236.php?aid=87801 Novel Biomarkers in Prediction of Heart Failure Related Outcomes From Benchto Bedside Berezin AE https://www.omicsgroup.org/journals/hypothyroidism-associated-with-echocardiographic-abnormalities-2165-8048-1000237.php?aid=88841 Hypothyroidism Associated with Echocardiographic Abnormalities Faiza A Qari https://www.omicsgroup.org/journals/a-67yearold-patient-with-severe-generalized-oedema-2165-8048-1000238.php?aid=88846 A 67YearOld Patient with Severe Generalized Oedema Raab A, Zelger B, Kofler H and Grander W https://www.omicsgroup.org/journals/is-methotrexate-mtx-necessary-in-combination-therapy-with-tocilizumaband-mtx-for-rheumatoid-arthritis-in-remission-cohort-study-ca.php?aid=87142 Is Methotrexate MTX Necessary in Combination Therapy with Tocilizumaband MTX for Rheumatoid Arthritis in Remission Cohort Study Carried by theMichinoku Tocilizumab Study Group